España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Oramed Pharmaceuticals
ORMP
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.40
-0.11
-4.38%
At close: -
$2.51
0.11
4.58%
After Hours: Dec 5, 4:02 PM EDT
Get Report
Comment
Oramed Pharmaceuticals (ORMP) Forecast
News
Earnings
Oramed Pharmaceuticals (ORMP) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Oramed Pharmaceuticals (NASDAQ:ORMP) Stock
Oramed Pharmaceuticals Stock (NASDAQ: ORMP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, October 07, 2024
Scilex Holding Company Announces Signing Of A...
Benzinga Newsdesk
Monday, September 09, 2024
HC Wainwright & Co. Reiterates Neutral on Ora...
Benzinga Newsdesk
Wednesday, June 26, 2024
Oramed Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Oramed Pharmaceuticals And Hefei Tianhui Biot...
Benzinga Newsdesk
Oramed Pharmaceuticals Authorizes $20M Buybac...
Benzinga Newsdesk
Wednesday, June 12, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Monday, May 20, 2024
HC Wainwright & Co. Reiterates Neutral on Ora...
Benzinga Newsdesk
Wednesday, May 15, 2024
Compugen Appoints David Silberman As Its New ...
Benzinga Newsdesk
Friday, February 02, 2024
Top 4 Health Care Stocks That May Crash This Quarter
Avi Kapoor
Tuesday, January 23, 2024
Oramed Pharmaceuticals Parties Intend For JV...
Charles Gross
Oramed Pharmaceuticals Said On Jan 22, Co And Unit Entered Into Joint Venture Agreement With Hefei Tianhui Biotech And Technowl; Oramed And HTIT Will Initially Hold Equal Shares In JV, With Each Owning 50% Of Equity
Charles Gross
Friday, September 22, 2023
Oramed Pharmaceuticals Secures $101.9M Senior...
Benzinga Newsdesk
Thursday, September 21, 2023
Scilex Assumed $100M In Debt Owed To Oramed P...
Benzinga Newsdesk
Scilex Holding Company Announces The Consumma...
Benzinga Newsdesk
Wednesday, September 13, 2023
Scilex Holding Company Enters Non-Binding Ter...
Bill Haddad
Wednesday, August 02, 2023
Oramed Signs Term Sheet With HTIT To Create A Joint Venture To Advance Oral Drug Delivery Technology Globally; HTIT To Invest $60M, Oramed To Invest $10M Into JV; Shares Spike Higher
Happy Mohamed
Friday, June 23, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Dow Tumbles 250 Points; CarMax Posts Upbeat Results
Lisa Levin
Wednesday, May 17, 2023
Canaccord Genuity Maintains Hold on Oramed Ph...
Benzinga Newsdesk
Tuesday, May 16, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Monday, May 15, 2023
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Why Oramed Pharmaceuticals Shares Are Trading Higher Today
Vandana Singh
Oramed Announces That Its Chinese Partner, HT...
Benzinga Newsdesk
Monday, May 01, 2023
Oramed Appoints Ben Shapiro To Board of Direc...
Michael Horton
Thursday, March 16, 2023
Director of Oramed Pharmaceuticals Makes $141K Buy
Benzinga Insights
Oramed Pharmaceuticals Chief Scientific Officer Sold $200K In Company Stock
Benzinga Insights
Thursday, February 09, 2023
Oramed Continues To Conduct Analysis Of Data ...
Benzinga Newsdesk
Oramed Pharmaceuticals To Explore Potential S...
Benzinga Newsdesk
Thursday, January 19, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, January 17, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Oramed Pharmaceuticals shares are trading low...
Michael Horton
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
Benzinga Insights
HC Wainwright & Co. Downgrades Oramed Pharmac...
Benzinga Newsdesk
Thursday, January 12, 2023
Gold Tops $1,900 After US CPI Report, S&P 500 Rises 0.5%
Lisa Levin
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
US Stocks Turn Higher; Dow Jumps 200 Points
Lisa Levin
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Dow Drops 150 Points; US Inflation Rate Slows In December
Lisa Levin
Benzinga Pro's Top 5 Stocks To Watch For Thur...
Benzinga Newsdesk
Oramed Pharmaceuticals shares are trading low...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Why Akerna Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Canaccord Genuity Downgrades Oramed Pharmaceu...
Benzinga Newsdesk
Oramed Pharma Shares Sink After Diabetes Candidate Fails In Phase 3 Study
Vandana Singh
Oramed Pharmaceuticals, Logitech International And Some Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Lisa Levin
Oramed Pharmaceuticals Shares Fall 70% Premar...
Charles Gross
Reported Late Wednesday, Oramed Pharmaceutica...
Benzinga Newsdesk
Thursday, January 05, 2023
Jim Cramer Says Avoid This Stock: 'Too Expensive'
Priya Nigam
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch